Edobles | Finanzwire

Basculer en Français

8295	Companies
114833	Keywords
55274	Articles
62430	Press releases

Home
Companies
Edobles

PRESS RELEASE

published on 02/05/2024 at 18:00, 9 months 15 days ago

Edobles Launches Mood-Enhancing Mushroom Gummies
Miami-based company, Edobles, launches latest product line, Mushroom Gummies, made from mushroom extracts to improve mood. The new Mushroom Gummies include well-known ingredients, such as Reishi, Cordyceps, Lion's Mane, Chaga Sclerotia, Maitake, and Turkey Tail mushrooms, chosen for their specific attributes to enhance moods. Edobles aims to empower individuals to employ mushrooms in their daily routine with the ultimate goal of helping them take control of their mood

Edobles Scientific Research Mushroom Gummies Mood-enhancing Natural Ingredients
PRESS RELEASE

published on 11/30/2023 at 18:00, 11 months 20 days ago

Edobles Launches Revolutionary Mood-Enhancing Edibles
Miami-based company, Edobles, introduces mood-enhancing edibles made with natural ingredient blends to cater to various moods, including euphoria, energy, calmness, balance, and restful sleep. Backed by scientific research and rigorous third-party lab testing, Edobles aims to revolutionize mood enhancement and well-being

Edobles Mood-enhancing Edibles Natural Ingredient Blends Scientific Research Lab Testing

Accesswire

Published on 11/21/2024 at 10:03, 43 minutes ago

Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 46 minutes ago

BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 46 minutes ago

ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 11 minutes ago

Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 21 minutes ago

Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 10:30, 16 minutes ago

MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 41 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 44 minutes ago

Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 46 minutes ago

Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 46 minutes ago

Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV

Les Echos

Published on 11/21/2024 at 06:58, 3 hours 48 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 26 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 1 minute ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago

Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo

View all LES ECHOS COMFI WIRE